How to Buy Roivant Sciences Stock
Roivant Sciences Ltd
Roivant Sciences Ltd. , a biopharmaceutical and healthcare technology company that researches and develops medicines.
Roivant Sciences stock last closed at $22.10, up 3.56% from the previous day, and has increased 86.03% in one year. It has overperformed other stocks in the Biotechnology industry by 1.31 percentage points. Roivant Sciences stock is currently +153.15% from its 52-week low of $8.73, and -1.54% from its 52-week high of $22.45.
There are currently 695.49M shares of ROIV outstanding. The market capitalization of ROIV is $15.37B. In the last 24 hours, 12.4M ROIV shares were traded.
How to Buy Roivant Sciences Stock
Wondering how to invest in Roivant Sciences stock? Here's how.
- Decide where to buy Roivant Sciences stock: You need to decide on a stock brokerage, but don't worry - we've sifted through dozens of online brokerages and apps to help you decide where to buy Roivant Sciences stock.
- Create your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
- Put funds into your brokerage account: Pick your method of payment and add your information.
- Evaluate Roivant Sciences stock: The Roivant Sciences ticker symbol is ROIV. Is Roivant Sciences stock a good investment? Should you buy shares of ROIV? How do ROIV's underlying business fundamentals look? Do top analysts think Roivant Sciences is a good buy? Why has ROIV's stock price moved recently? (Hint: Our stock market analysis website can help you evaluate if ROIV is a good stock to buy).
- Place your ROIV purchase: Decide if you will purchase ROIV shares at the current market price or use a limit order to purchase ROIV shares at a given price.
- Get key alerts regarding your ROIV investment: Create a watchlist to important notifications about your investment in Roivant Sciences shares.
Step 1: Decide where to buy Roivant Sciences stock
You will need an online brokerage account in order to access the NASDAQ market and buy ROIV shares.
Our favorite brokerage: eToro
In our opinion, eToro is the best place to buy stocks. Here's why:
- Invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
- Access to global markets: From Tech to Industrials, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top exchanges.
- Social investing: eToro boasts a community of more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by creating an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Create your brokerage account
Now that you've selected your brokerage, the next step is to fill out some personal details so you are able to buy ROIV today.
How to Set Up a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal details to create a new brokerage account.
- Send your info by hitting the "Create Account" button. Get started with eToro today
Step 3: Put funds into your brokerage account
Now that you've created your account on the best stock trading app for beginners, your next step is to transfer the money for your investment:
Check out the walkthrough below for more details transferring money into your investment account.
Step 4: Evaluate Roivant Sciences stock
After you have figured out the best place to buy Roivant Sciences stock, it's critical to research their stock before you invest, so you truly understand the risk as well as the opportunity.
Roivant Sciences shares at a glance
Fundamentals of ROIV
WallStreetZen was built to help everyday investors do better fundamental analysis quickly.
You can view all of the due diligence checks on ROIV's stock page.
What is the fair value of ROIV stock?
You can use many financial metrics, analyses, models, and charts to gauge ROIV's intrinsic value.
Using relative valuations metrics:
- ROIV may be undervalued based on its P/B ratio of 3.52x, relative to Biotechnology industry P/B ratio of 5.32x
You can access additional valuation research on ROIV's stock here.
ROIV Financial Health Overview
Signs that ROIV is financially healthy:
- ROIV has cash burn of 784384000. It has sufficient cash and short-term investments to cover this for at least one year.
- There are more short-term assets than long-term liabilities on the ROIV balance sheet.
- There are more short-term assets than short-term liabilities on the ROIV balance sheet.
- Total ROIV debt is lower than 5 years ago, relative to shareholder equity.
- ROIV has $4.39B in cash and short term investments. This is enough to cover its annual cash burn of $784.38M.
- ROIV has a low debt to equity ratio of 0.06.
Signs that ROIV is not financially healthy:
- ROIV profit margin has gone down from 12,984% to -1,839.6% in the past year.
Is ROIV stock a Buy, Hold, or Sell, according to Wall Street analysts?
Out of 8 sell side analysts who give forecasts on ROIV, the consensus analyst rating on Roivant Sciences is a Strong Buy
Please keep in mind that analyst forecasts are not recommendations, nor are they investment advice.
Most Recent ROIV Analyst Forecasts
Yatin Suneja, a top 4% analyst from Guggenheim maintains ROIV with a strong buy rating and raises their ROIV price target from $15.00 to $21.00, on Sep 18, 2025.
Guggenheim's Yatin Suneja raised their price target on Roivant Sciences (NASDAQ: ROIV) by 40% from $15 to $21 on 2025/09/18. The analyst maintained their Strong Buy rating on the stock.
On 2025/09/17, Roivant Sciences announced positive Phase 3 VALOR Study results for brepocitinib in a 52-week placebo-controlled trial in DM (Dermatomyositis), Suneja told readers.
According to the analyst, Brepo 30 mg saw a "remarkable" mean total improvement score of 46.5.
With a 50% peak penetration rate and 100% probabilities of brepo success in DM, Suneja revised their model and now predicts peak sales of approximately $2B.
Footnotes
Brepocitinib is an investigational oral drug that inhibits two key immune signaling proteins for treating immune-mediated diseases.
Dermatomyositis is a rare inflammatory disease that affects both the skin and muscles, leading to a distinctive rash and progressive muscle weakness. It’s classified as an idiopathic inflammatory myopathy, meaning its exact cause is unknown, though it’s believed to involve autoimmune mechanisms.
David Risinger, a top 10% analyst from Leerink Partners maintains ROIV with a buy rating and raises their ROIV price target from $18.00 to $22.00, on Sep 18, 2025.
Chi Fong, a bottom 22% analyst from Bank of America maintains ROIV with a hold rating and raises their ROIV price target from $12.00 to $16.50, on Sep 18, 2025.
You can dig deeper into what analysts are saying on the Roivant Sciences stock forecast page.
ROIV Trading Indicators
ROIV Growth Metrics
Last year, ROIV revenue was $20.33M. During the last 4 year, ROIV's revenue has increased by -16.89% per year. This was slower than the Biotechnology industry average of 43.8%.
Dig into ROIV's earnings and revenue performance here.
Latest Insiders Trades at ROIV
Over the last year, executives and large shareholders at ROIV have sold more shares than they have bought.
Eric Venker, President Immunovant CEO of ROIV, was the latest ROIV insider to buy. They bought $770,000.00 worth of ROIV stock on Dec 9, 2025.
Get more info about who owns ROIV stock here.
Can I get consistent income from ROIV stock?
No, Roivant Sciences doesn't provide an income stream by paying out dividends.
What do other investors have to say about ROIV?
One of the primary reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other community members have to say.
Step 5: Place your ROIV purchase
You have two main order types:
- Market order: A market order is an order to buy or sell a stock at the best available price.
Market orders are generally sufficient. - Limit order: A limit order lets you buy or sell a security at a specific price (or better).
If you want to make sure you're buying or selling at an exact price limit, use a limit order.
Hit the Open Trade button and your broker will execute your order.
If you need additional help buying stocks on eToro, watch the how to video below:
Step 6: Get key alerts regarding your ROIV investment
Now that you own some ROIV shares, you'll want to stay up-to-date on your new stock purchase.
Start a watchlist to see the latest developments about your ROIV stock.
ROIV Feed
How to Buy Stock in Roivant Sciences
To reiterate, here are the 6 steps to buy stock in Roivant Sciences:
- Decide where to buy Roivant Sciences stock
- Create your brokerage account
- Put funds into your brokerage account
- Evaluate Roivant Sciences stock
- Place your ROIV purchase
- Get key alerts regarding your ROIV investment
If you need a brokerage account, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to track your investment in Roivant Sciences, create your watchlist below.
More Stock Buying Guides You May Like
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.